Abstract: Endometrial cancer is the most common gynecologic malignancy in the United
Introduction
Endometrial cancer is very common cancer in women and the fourth most repeatedly diagnosed cancer in the United States [1] . Irregular menstruation or postmenopausal bleeding considers symptoms to early endometrial cancer diagnosis [2] . More than 90% of women with endometrial cancer occur in women older than 50 years of age, with a median age of 63 years [3] . Hormones are substances acts as intercellular messengers that produced by the ductless glands and released into the bloodstream [4] . Chemical structures of some hormones are steroids such as female sex hormones (estrogen, progesterone) [5] . Estrogens (ES) are female sex hormones contribute in development and growth of female genital and female sex characteristics, E2are synthesized in the ovary, placenta, testes and adrenal cortex [6] . E2 functions: Sexual behavior in male and female, Secondary female sex characteristics, ovulation, support (with progesterone) uterine endometrium, Regulation of cardiovascular physiology Bone integrity and neuronal growth [7] . Progesterone (P4), also known as pregn-4-ene-3, 20-dione [8] , the main source of progesterone in humans is the ovarian corpus luteum, the adrenal glands, and during pregnancy the main source of P4 is the placenta. P4 is also stored in adipose (fat) tissue [9] . Important functions of P4: regulate sexual behavior; keeping the pregnancy by inhibiting uterine contractions, promoting the development in the endometrium and the mammary gland for lactation, participate in the female menstrual/menstrual cycle and the embryogenesis of humans and other species [10] . Obesity caused endogenous overproduction of E2 mainly through changes in endogenous hormone metabolism. After menopause when ovarian stopped production of both E2 and P4, the major source of E2 become from conversion of androstenedione to estrone in adipose tissue so with obesity there is great amount of E2 in the circulation and the endometrial tissue [11] . In premenopausal women the obesity may also increase the risk endometrial cancer through hyperinsulinemia which be the mainly factor for development of ovarian hyperandrogenism, associated with anovulation and P4 deficiency [12] .
II. Materials and Methods
Serum concentrations of hormones were measured byELISA assay, and the weight, height, waist and hip were measured.
Subjects
The present investigation was carried out at departments of the Medical city (Oncology teaching hospital and Baghdad hospital) in Baghdad, Iraq. The study included collection the blood samples from fifty six endometrial cancer women patients beforetherapy; age range was between 27-76 years.Thirtyhealthyfemales ). Patients were taken as obese if their body mass index was 29.9 [13] . Waist: hip ratio (WHpR) was calculated by dividing waist by hip measurements [14] . Waist: height ratio (WHtR) was calculated by dividing waist by height measurements.
Samples Analysis

Specimen collection
Fasting blood samples (10 mL) were collected and placed into plane tubes. After centrifugation at 1500×g for 10 min, the sera were removed and retained for assay of the level of E2 and P4. Serum samples were stored at -80Cº until analysis.
2.3.2
Laboratory assessmentsLaboratory assessments Serum concentration ofE2 and P4 were measured by ELISA test for the quantitative determination of E2 and P4 in human serum that supplied by Human Gesellschaft, Germany.
Statistical analysis
All data were expressed as mean ± standard deviation (mean ± SD). Statistical analysis was performed using LSD, considering p < 0.05 as the lowest limit of significance. Statistical analysis was performed using a software program (SPSS 13 for Windows, USA). One-way analysis of variance (ANOVA) was used to compare means with least significant difference (LSD).
III.
Results Table 1 displayed a highly significant increased (p<0.01) in ageof endometrial cancer compared to control group. There is a significant difference in systolic and diastolic blood pressure, while non-significant differences in (height and hip) between endometrial cancer patients and control groups, the majority of cancer family history and married women (presenting %) estimated in endometrial cancer patients group, while the lowest recorded in control group. The presenting of Physical Activity and drinking coffee revealed in control group as compared to patients. Table 2 displayed a highly significant increased (p<0.01) in (BMI Kg/m 2 , WHtR, and WHpR), and significant increase (p<0.01) in E2 pg/mL and P4 ng/mL hormones in women patients with endometrial cancer when compared to control group. Table 3 display a highly significant increased (p<0.01) in P4 and non-significant differences in E2 when compared between endometrial cancer patients in different stages and control group by using ANOVA test. Table 4 showed E2 and P4 according to BMI of endometrial cancer women patients. There was significant difference (p<0.05) in E2 between normal weight, overweight and obese of endometrial cancer patients and control group. On other hand a highly significant increased (p<0.0001) was observed in P4 between normal weight, overweight and obese of endometrial cancer patient and control groups. 
IV. Discussion
Age is an important risk factor for endometrial cancer. Most women are diagnosed after menopause, The women after 40 years are the most exposure to endometrial hyperplasia it is an abnormal increase in the number of uterus cells, is not a cancer but may be develops into cancer [15] . Coffee compounds prevent the initiation phase of the carcinogenic process, decrease damage of DNA and protect cells against reactive oxygen species (ROS) [16] . The risk of endometrial cancer increased with a family history of endometrial cancer because of genetic factors [17] . Hypertension positively associated with endometrial cancer risk in models adjusted for BMI [18] . Physical activity is a modifiable risk factor related to obesity which regulates hormonal, metabolic pathways and helps control body weight, thus may protect against endometrial cancer [19] .The risk of endometrial cancer increases linearly with increasing BMI, the risk is increased in women with a body mass index (BMI) greater than 30 (kg/m 2 ) [20] . Obesity causes excess of E2 because adrenal androgens are converted to E2 by adipose tissue. E2s bind directly to DNA of endometrial cell and this lead to increase transcription and interact with several growth factor signaling pathways to promote proliferation, [21, 22] . In obese premenopausal women the ovarian activity became weaker leading to markedly reduced synthesis, thus reduced P4 levels. The role of P4 in the endometrium is protective against the stimulatory effects of estrogens so decrease in normal P4 level in obese premenopausal women can increased the risk of endometrial cancer [23] . E2 act as tumor initiators, tumor promoters and increases the risk of developing endometrial cancer when exposure to E2 not opposed by P4. The mechanism is estrogen-induced stimulation of endometrial cell proliferation which promotes the probability of occurrence and accumulation of mutations [24] . P4 has the ability to resistance proliferation and promotes atrophy of the endometrium; therefor P4 and its derivatives (progestin) have been used successfully as therapeutics to treat endometrial hyperplasia and cancers [25] . Continuous exposure to imbalances of sex steroid, when there is deficient P4 or excessive E2 this can result in endometrium hyperplasia and may be then to atypical hyperplasia and endometrial cancer [26] . Obesity is one of [28] . Postmenopausal women have high E2 levels through converted aromatization of androgens in adipose tissue and increases of free E2 among overweight/obese postmenopausal women lead to promoting the development of breast cancer [29] . The unbalance between E2 and P4 lead to increases proliferation and promotion tumors growth of endometrial cells, thus increased cancer development risk to advanced stages.Also genetic mutations maybe initiated the growth of endometrial cancer, [30] . Increase E2 levels in obese individuals result from aromatized androgens and act with E2 metabolites to cause cancer, (31).Wallace et alshowed that unbalance between E2 and P4 lead to increases proliferation and promotion tumors growth of endometrial cells, thus increased cancer development risk to advanced stages [30] .
V. Conclusion
Evidence suggests that nutrition and lifestyle factors favoring the development of obesity may increase endometrial cancer risk via effects on endogenous hormones levels. In premenopausal women may increase endometrial cancer risk by inducing chronic anovulation and P4 deficiency. In postmenopausal women may increase endometrial cancer risk by increasing bioavailable E2.
